Media Releases

WuXi AppTec, leading China-based CRO, chooses CAS SciFinder to advance its R&D competitiveness

November  01, 2010 - 

Shanghai, China - Chemical Abstracts Service (CAS), the world's authority for chemical information, announced today that WuXi AppTec, the leading China-based contract research organization (CRO), has signed a contract to provide SciFinder for all scientists within their organization. In 2009, a CAS analysis of chemical literature showed that China led all nations in chemical patent publications and was surging in output of journal literature. WuXi AppTec is convincing proof of the continuous investment and ambition of China-based corporations to lead the world market in the field of chemical research.  

Scientists recognize SciFinder as a leading research tool for chemists and related scientists. With streamlined navigation, an intuitive interface, and secure access to CAS content, SciFinder makes it simple to quickly find the right information to support research and make decisions with confidence. "We are pleased to select SciFinder to advance our R&D competitiveness. As a knowledge-based, problem-solving provider of broad chemistry-based services, WuXi will have instant access to more than 10,000 journals and 61 patent authorities, using an intuitive interface to seek out the latest in state-of-the-art research in addition to the wealth of a century of scientific information, thereby enabling our scientific team to more effectively address our customers needs in chemistry R&D," commented Dr. Ge Li, chairman and CEO of WuXi AppTec.

China's pharmaceutical market is growing rapidly. In the last decade, Chinese invention applications increased by nearly 1,400 percent, with much of that growth taking place in the pharmaceutical sector. More than half of the Chinese patent applications during this period were from inventors within China, which indicates that Chinese scientists now also recognize the importance of monetizing research discoveries. CAS has served chemists and other scientists for more than 100 years. "We are honored to share our long-standing experience and comprehensive resources with WuXi AppTec, and also to be part of the advancement of pharmaceutical discovery and innovation in China, the fastest growing market in the world, said Robert Massie, president of CAS.

CAS has already built a solid relationship with hundreds of Chinese companies and multinational corporations operating in China, along with more than 80 key universities and research institutions. CAS has partnered for decades with Chinese organizations, including the State Intellectual Property Office of the People's Republic of China (SIPO), to build its information resources.


About CAS

Chemical Abstracts Service (CAS), a division of the American Chemical Society, is the world's authority for chemical information. CAS is the only organization in the world whose objective is to find, collect and organize all publicly disclosed substance information. A team of scientists worldwide curates and controls the quality of our databases, which are recognized as the most comprehensive and authoritative by chemical and pharmaceutical companies, universities, government organizations and patent offices around the world. By combining these databases with advanced search and analysis technologies (SciFinder® and STN®), CAS delivers the most current, complete, secure and interlinked digital information environment for scientific discovery.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       


Recent News

    March 17, 2015 | New Content Provides Regulatory
    Professionals with Additional Value
    February 9, 2015 | Major New STN Release Delivers
    Essential Biomedical and Patent Content to IP
    January 26, 2015
 | Annual MEDLINE Reload on STN
    Features Enhanced Clinical Trial Information and the
    2015 MeSH Thesaurus
                                                                     More News >>